Get started
Author

Julie Pires Da Silva

SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation
2016 · Alexandre Prola, Julie Pires Da Silva, et al. · Cell Death and Differentiation · 215
Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation
2018 · Giada Zurlo, Jérôme Piquereau, et al. · Journal of Hypertension · 69
SIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy
2020 · Julie Pires Da Silva, Kevin Monceaux, et al. · Cells · 60
PDF
SIRT1 protects cardiac cells against apoptosis induced by zearalenone or its metabolites α- and β-zearalenol through an autophagy-dependent pathway
2016 · Intidhar Ben Salem, Manel Boussabbeh, et al. · Toxicology and Applied Pharmacology · 57
Endoplasmic reticulum stress induces cardiac dysfunction through architectural modifications and alteration of mitochondrial function in cardiomyocytes
2018 · Alexandre Prola, Zuzana Nichtova, et al. · Cardiovascular Research · 52
Ferulic Acid, Pterostilbene, and Tyrosol Protect the Heart from ER-Stress-Induced Injury by Activating SIRT1-Dependent Deacetylation of eIF2α
2022 · Kévin Monceaux, Mélanie Gressette, et al. · International Journal of Molecular Sciences · 45
PDF
Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling
2022 · Rushita A. Bagchi, Emma L. Robinson, et al. · Proceedings of the National Academy of Sciences · 37
Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis
2020 · Agathe Leblond, Sonia Pezet, et al. · Annals of the Rheumatic Diseases · 28
PDF
Citrinin induces apoptosis in human HCT116 colon cancer cells through endoplasmic reticulum stress
2017 · Amal Salah, Chayma Bouaziz, et al. · Journal of Toxicology and Environmental Health · 26
Serum circulating proteins from pediatric patients with dilated cardiomyopathy cause pathologic remodeling and cardiomyocyte stiffness
2021 · Danielle A. Jeffrey, Julie Pires Da Silva, et al. · JCI Insight · 18
Effects of Dichlorvos on cardiac cells: Toxicity and molecular mechanism of action
2023 · Intidhar Ben Salem, Manel Boussabbeh, et al. · Chemosphere · 17
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study
2022 · Julie Pires Da Silva, Matthieu Wargny, et al. · Diabetes & Metabolism · 11
P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease
2024 · Thibaut Duparc, Emilia Gore, et al. · JCI Insight · 10
PDF
Application of microRNA Database Mining in Biomarker Discovery and Identification of Therapeutic Targets for Complex Disease
2020 · Jennifer L. Major, Rushita A. Bagchi, et al. · Methods and Protocols · 8
PDF
Research Gaps in Pediatric Heart Failure: Defining the Gaps and Then Closing Them Over the Next Decade
2023 · SHAHNAWAZ AMDANI, SCOTT R. AUERBACH, et al. · Journal of Cardiac Failure · 7
Serum Metabolic Profiling Identifies Key Differences between Patients with Single-Ventricle Heart Disease and Healthy Controls
2022 · Julie Pires da Silva, Ashley E. Pietra, et al. · International Journal of Translational Medicine · 7
PDF
Mitochondrial Dysfunction in Congenital Heart Disease
2025 · Julie Pires Da Silva, Mariana Casa de Vito, et al. · Journal of Cardiovascular Development and Disease · 6
PDF
Serum response factor deletion 5 regulates phospholamban phosphorylation and calcium uptake
2021 · Kathleen C. Woulfe, Danielle A. Jeffrey, et al. · Journal of Molecular and Cellular Cardiology · 4
Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension
2020 · Jessica Y. Hsu, Jennifer L. Major, et al. · Biochemistry and Cell Biology · 4
PDF
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: a prospective cohort study
2022 · Julie Pires Silva, Matthieu Wargny, et al. · Research Square · 3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: a prospective cohort study
2022 · Julie Pires Silva, Matthieu Wargny, et al. · Research Square · 2
PDF
Impact of Serum Circulating Factors and PDE5 Inhibitor Therapy on Cardiomyocyte Metabolism in Single Ventricle Heart Disease
2025 · Anastacia M. Garcia, Ashley E. Pietra, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Editorial: The intersection of gene regulation and metabolism in cardiovascular disease
2023 · Julie Pires Da Silva, Pamela A. Padilla, et al. · Frontiers in Genetics · 1
PDF
Circulating Factors in Single Ventricle Heart Disease Impair Cardiomyocyte Bioenergetics, With Partial Rescue by PDE5 Inhibition
2026 · Anastacia M. Garcia, Ashley E. Pietra, et al. · Journal of the American Heart Association
Abstract 4368729: Temporal progression of cardiac dysfunction in HFD+L-NAME model associated with metabolic impairment and mitochondrial functional defect.
2025 · Rana Assaly, Julie Pires Da Silva, et al. · Circulation
Works count: 37
Citation count: 688
H-index: 11
I10-index: 13
Year
Topic
Type